Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd, commonly referred to as Sirtex, is a leading Australian biotechnology company headquartered in Sydney, Australia. Founded in 2000, Sirtex has established itself as a pioneer in the field of targeted cancer therapies, particularly through its innovative SIR-Spheres® microspheres, which deliver selective internal radiation therapy for liver cancer. With a strong presence in major operational regions including North America, Europe, and Asia, Sirtex is dedicated to improving patient outcomes through its unique approach to cancer treatment. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Sirtex continues to be recognised for its commitment to advancing cancer care, making it a notable player in the global oncology landscape.
DitchCarbon Score
How does Sirtex Medical Pty Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sirtex Medical Pty Ltd.'s score of 16 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sirtex Medical Pty Ltd.'s reported carbon emissions
Sirtex Medical Pty Ltd., headquartered in Australia, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives available at this time. Sirtex Medical Pty Ltd. has not publicly committed to any specific climate pledges or initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company’s current stance on carbon emissions and climate action remains unclear, highlighting a potential area for future development in sustainability practices within the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sirtex Medical Pty Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
